Bayer Earnings, Revenue beat In Q2
Investing.com - Bayer (ETR:BAYGN) reported on Thursday second quarter {{erl-346||earnings that beat analysts' forecasts and revenue that topped expectations. Bayer announced earnings per...
Strong Buy
or
Bayer News & Analysis
-
-
Dow Jones Newswires: Bayer trims losses and raises 2022 forecasts
The German pharmaceutical-and-agricultural company posted a net loss of 298 million euros ($303m) for Q2, narrowed from a loss of EUR2.34bn the year prior
-
Bayer’s agriculture unit, consumer health drives improved outlook for 2022
FRANKFURT (Reuters) – Agriculture and pharmaceuticals company Bayer on Thursday lifted its 2022 earnings guidance on strong demand from farmers for its seeds and crop chemicals and...
-
Bayer and Maersk: A 20-year-old partnership of innovation
The customer Bayer, one of the largest pharmaceutical and life science companies in the world, has been at the forefront of the production of medicines and crop protection products. Company...
-
Bayer to sell Nebido testosterone treatment in deal worth up to $500 million
BERLIN (Reuters) – Bayer is selling its testosterone treatment Nebido to German pharmaceutical firm Gruenenthal in a deal valued up to 500 million euros ($500.95 million), it said on...
-
Bayer, BASF win new trial on $60 million damage award in weedkiller lawsuit
By Brendan Pierson (Reuters) – Bayer AG and BASF have won a new trial on $60 million in punitive damages they were ordered to pay a Missouri peach farmer who said dicamba, a herbicide...
-
'Off the charts' chemical shortages hit U.S. farms
By Tom PolansekCHICAGO (Reuters) - U.S. farmers have cut back on using common weedkillers, hunted for substitutes to popular fungicides and changed planting plans over persistent shortages...
-
Investors & Farmers Stick with Bayer Despite Latest Court Ruling
This week, life science company Bayer’s (BAYRY) appeal to stop thousands of lawsuits that claim the company’s Roundup (a weedkiller) causes cancer was rejected by the Supreme Court. The...
-
Supreme Court rejects Bayer bid to stop Roundup lawsuits
Supreme Court rejects Bayer bid to stop Roundup lawsuits
-
Supreme Court Declines to Hear Bayer Appeal on Roundup
The high court’s decision not to hear case leaves German conglomerate exposed to billions of dollars in potential settlement costs.
-
U.S. Supreme Court rejects Bayer bid to nix Roundup weedkiller suits
WASHINGTON (Reuters) – The U.S. Supreme Court on Tuesday rejected Bayer AG’s bid to dismiss legal claims by customers who contend its Roundup weedkiller causes cancer as the German...
-
Bayer wins fourth Roundup weedkiller case in U.S
FRANKFURT (Reuters) – A U.S. jury found Bayer’s Roundup weedkiller did not cause an Oregon man’s cancer, the German agriculture and pharmaceuticals company said on Saturday, handing the...
-
U.S. Supreme Court takes no action on Bayer bid to nix weedkiller suits
WASHINGTON (Reuters) – The U.S. Supreme Court on Monday took no action on Bayer AG’s bid to dismiss legal claims by customers who contend its Roundup weedkiller causes cancer as the...
-
Bayer Wins Roundup Cancer Case Ahead of Supreme Court Move
The German agricultural and pharmaceutical giant notched a third consecutive court victory in the U.S. over its Roundup weedkiller
-
U.S. Supreme Court will soon decide whether to hear Bayer’s weedkiller case
By Lawrence Hurley and Ludwig Burger WASHINGTON/FRANKFURT (Reuters) – The U.S. Supreme Court could announce as soon as Monday whether it will hear Bayer’s bid to dismiss claims its...
-
Is Bayer Ready for Its Long-Due Resurrection?
Due to Russia’s invasion of Ukraine, there is an inherent threat of possible global food shortages in the coming months as Ukraine is one of the biggest exporters o...
-
Bayer's Agricultural Unit Thrives as Ukraine War Threatens Food Supplies
The German conglomerate’s $63 billion bet on Monsanto is finally showing signs of paying off, as food shortages stoked by Russia’s invasion of Ukraine drive demand for seeds and...
-
Bayer Earnings, Revenue beat In Q1
Investing.com - Bayer (ETR:BAYGN) reported on Tuesday first quarter {{erl-346||earnings that beat analysts' forecasts and revenue that topped expectations. Bayer announced earnings per...
-
Bayer Reports Strong 1Q; Crop Science Thrives as Grains Prices Soar
By Geoffrey Smith Investing.com -- German conglomerate Bayer (ETR:BAYGN) took another step on the road to recovery on Tuesday, posting strong first-quarter earnings thanks to a revived...
-
European Stock Futures Edge Higher; Sentiment Weak on Recession Fears
By Peter Nurse Investing.com - European stock markets are expected to open marginally higher Tuesday, rebounding to a degree after the previous session’s selloff, but investors continue to...
-
Bayer Gains as Investor Temasek Calls for CEO Baumann’s Ouster
By Dhirendra Tripathi Investing.com – Bayer (DE:BAYGN) stock traded 2.7% higher Monday in Frankfurt after reports that Singapore’s Temasek, a long-term investor, is calling for the removal...
-
Bayer Earnings, Revenue beat In Q1
Investing.com - Bayer (DE:BAYGN) reported on Tuesday first quarter {{erl-346||earnings that beat analysts' forecasts and revenue that topped expectations. Bayer announced earnings per...
-
Bayer Gains on Projecting Profits Will be Higher This Year
By Dhirendra Tripathi Investing.com – Bayer AG (DE:BAYGN) stock traded 1.5% higher in Frankfurt trading Tuesday after the company forecast its adjusted profits will return to growth in...
-
2022 Smartphone camera trends
Smartphone cameras are no longer just the most convenient option – they are quickly becoming the best one, beating traditional digital cameras with computational power and...
-
Bayer Earnings, Revenue beat In Q3
Investing.com - Bayer (DE:BAYGN) reported on Tuesday third quarter {{erl-346||earnings that beat analysts' forecasts and revenue that topped expectations. Bayer announced earnings per...
-
Marketmind: Melt up?
A look at the day ahead from Sujata Rao.Is this a melt-up?As confidence grows that the world's biggest central banks are in no hurry for raising interest rates despite progress on the jobs...
-
Marketmind: Hunker down, it's going to be one of those days
A look at the day ahead from Dhara Ranasinghe.U.S. and European bond yields are up sharply, stock market futures are deep in the red and oil is holding near multi-year highs. Yes, it's going...
-
U.S. farmers face supply shortages, higher costs after Hurricane Ida
By P.J. Huffstutter and Mark Weinraub CHICAGO (Reuters) - Troy Walker's phone will not stop ringing at his Kansas farm cooperative, with growers needing fertilizer for their wheat fields in...
-
Bayer Earnings, Revenue beat In Q2
Investing.com - Bayer (DE:BAYGN) reported on Thursday second quarter {{erl-346||earnings that beat analysts' forecasts and revenue that topped expectations. Bayer announced earnings per...
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
